Altus Pharmaceuticals Inc. Executive Officer Compensation Summary (2005–2006)
Contract Categories:
Human Resources
›
Compensation Agreements
Summary
Altus Pharmaceuticals Inc.'s Compensation Committee approved the 2005 bonuses and 2006 base salaries for its CEO and four top executive officers. The bonuses were based on company performance and individual goals. For 2006, executives are eligible for cash bonuses up to 20% of base salary, except the CEO, who may receive up to 50%, depending on performance. Additionally, stock options were granted to these officers, vesting over four years. This summary outlines the compensation structure and incentives for Altus's key executives for the specified period.
EX-10.27 5 b57089a5exv10w27.txt EX-10.27 SUMMARY OF EXECUTIVE COMPENSATION EXHIBIT 10.27 ALTUS PHARMACEUTICALS INC. EXECUTIVE OFFICER COMPENSATION INFORMATION The Compensation Committee of the Board of Directors (the "Compensation Committee") of Altus Pharmaceuticals Inc. ("Altus") has approved the 2005 fiscal year cash bonuses and 2006 fiscal year annual base salaries, effective as of January 1, 2006, of Altus' Chief Executive Officer and its four other most highly compensated executive officers who were employed by us as of December 31, 2005 and earned more than $100,000 in salary and bonus for the year ended December 31, 2005 (the "named executive officers").
The 2005 fiscal year cash bonuses for Altus' Chief Executive Officer and the named executive officers was determined by the Compensation Committee based upon overall corporate performance together with a subjective assessment by the Compensation Committee of each officer's achievement of previously established performance goals which relate to the officer's areas of responsibility. (1) For the 2006 fiscal year, the named executive officers are eligible to receive a cash bonus of up to 20% of their base salary, except for Altus' Chief Executive Officer, who is eligible to receive a cash bonus of up to 50% of his base salary, upon the achievement of individual performance goals. In addition, on January 9, 2006, the Compensation Committee granted options to the named executive officers to purchase shares of Altus' common stock, $.01 par value per share, each at an exercise price of $11.47 per share, as follows: Sheldon Berkle received an option to purchase 26,166 shares; Don G. Burstyn, Ph.D., received an option to purchase 15,262 shares; Robert Gallotto received an option to purchase 27,890 shares; Jonathan I. Lieber received an option to purchase 26,488 shares; and Alexey L. Margolin received an option to purchase 26,954 shares. Each of such options has a term of ten years vesting over four years, with 1/16th of the options vesting every three months. These numbers have been adjusted to reflect the 1-for-2.293 reverse stock split that took effect in January 2006. Further information with respect to the compensation of Altus' named executive officers is set forth in the Registration Statement on Form S-1 (File No. 333-129037).